WebApr 2, 2024 · Hu Q, Han YL, Zhou TN, Wang XZ, Zhang QY. Efficacy and Safety of the Reduced Bivalirudin in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention Stratified by Renal Function (REDUCE BOLUS): A Single-Blind, Stratified Randomized, Non-inferiority Trial. Front Cardiovasc Med. 2024 Apr … WebRecent data have demonstrated bivalirudin has the potential to surpass and replace heparin as the anticoagulant of choice.MethodsWe conducted a systematic review comparing the outcomes of heparin-based versus bivalirudin-based anticoagulation in pediatric patients supported on ECMO to identify the preferred anticoagulant to minimize …
Bivalirudin UW Medicine Anticoagulation Services
WebMay 19, 2024 · The use of anticoagulation for intermittent hemodialysis (HD) is common due to the propensity for clotting within the circuit. However, the decision to administer anticoagulation begins with assessment of a patient's bleeding risk. Patients who are on HD are generally prothrombotic, especially after a surgical procedure, and have an increased ... WebPMCID: PMC8352815 DOI: 10.1007/s11096-021-01260-z Abstract Background Argatroban, lepirudin, desirudin, bivalirudin, and danaparoid are commonly used to manage heparin-induced thrombocytopenia related complications. However, the most suitable drug for this condition still remains controversial. tim pippart wanfried
Bivalirudin - StatPearls - NCBI Bookshelf
Webthe relative treatment effects of bivalirudin compared with heparin were consistent in patients treated with ticagrelor and clopidogrel. As we also noted, we are not aware of … WebThe adult bivalirudin group had a greater occurrence of heparin-induced thrombocytopenia (12% vs 1%; p < 0.01) and was more likely to require postcardiotomy extracorporeal … WebThe main finding was that bivalirudin did not significantly reduce the incidence of the quadruple end point — that is, did not provide a net clinical benefit — as compared with unfractionated... partnership community action decatur ga water